Latest filing published 01 Nov 2006 for CALMARE THERAPEUTICS Inc.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Michael E. Kiley: trading record in brief
Michael E. Kiley appears in our data through filings on CALMARE THERAPEUTICS Inc shares, published by SEC (Form 4). Over a trading history stretching from 10 March 2006 to 31 October 2006, the count stands at 7 filings.
Purchases make up the whole of the open-market record (6 purchases, €15k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 1 share grant.
A typical purchase (the median) is worth €2,308.
Most recently, on 1 November 2006, the filings show a share grant in CALMARE THERAPEUTICS Inc. The most recent open-market purchase was published on 1 November 2006, 7,313 days ago. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Michael E. Kiley
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,357 shares0Common StockSEC:0001346805-06-000006:0
- 2,000 shares@ US$2.65Common StockSEC:0001346805-06-000006:1Canonical exit: 29 Jan 2007 (T+90)
- 1,000 shares@ US$2.27Common StockSEC:0001346805-06-000004:0Canonical exit: 26 Oct 2006 (T+90)
- 1,000 shares@ US$3.27Common StockSEC:0001346805-06-000003:0Canonical exit: 23 Jul 2006 (T+90)
- 500 shares@ US$3.20Common StockSEC:0001346805-06-000002:0Canonical exit: 20 Jun 2006 (T+90)
- 900 shares@ US$3.95Common StockSEC:0001346805-06-000001:0Canonical exit: 8 Jun 2006 (T+90)
- 600 shares@ US$3.94Common StockSEC:0001346805-06-000001:1Canonical exit: 8 Jun 2006 (T+90)
7 of 7 declarations